Redmile Group as of June 30, 2019
Portfolio Holdings for Redmile Group
Redmile Group holds 80 positions in its portfolio as reported in the June 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Array BioPharma | 11.5 | $406M | 8.8M | 46.33 | |
Amicus Therapeutics (FOLD) | 8.0 | $285M | 23M | 12.48 | |
Fate Therapeutics (FATE) | 6.0 | $210M | 10M | 20.30 | |
Argenx Se Sponsored Adr (ARGX) | 4.3 | $151M | 1.1M | 141.58 | |
Uniqure Nv SHS (QURE) | 3.7 | $131M | 1.7M | 78.15 | |
Audentes Therapeutics | 3.2 | $113M | 3.0M | 37.86 | |
Epizyme | 3.1 | $110M | 8.7M | 12.55 | |
Allakos (ALLK) | 2.8 | $100M | 2.3M | 43.33 | |
Alder Biopharmaceuticals | 2.7 | $97M | 8.2M | 11.77 | |
Atara Biotherapeutics (ATRA) | 2.6 | $93M | 4.6M | 20.11 | |
Tricida | 2.2 | $77M | 1.9M | 39.46 | |
eHealth (EHTH) | 2.2 | $77M | 889k | 86.10 | |
Bristol Myers Squibb (BMY) | 2.1 | $76M | 1.7M | 45.35 | |
Tandem Diabetes Care Com New (TNDM) | 2.1 | $75M | 1.2M | 64.52 | |
Regenxbio Inc equity us cm (RGNX) | 2.0 | $72M | 1.4M | 51.37 | |
Wave Life Sciences SHS (WVE) | 2.0 | $71M | 2.7M | 26.09 | |
Wright Med Group N V Ord Shs | 2.0 | $71M | 2.4M | 29.82 | |
Xencor (XNCR) | 1.9 | $66M | 1.6M | 40.93 | |
Sarepta Therapeutics (SRPT) | 1.8 | $63M | 412k | 151.95 | |
Anthem (ELV) | 1.5 | $52M | 184k | 282.21 | |
Celgene Corporation | 1.5 | $52M | 557k | 92.44 | |
Clovis Oncology | 1.5 | $52M | 3.5M | 14.87 | |
Array Biopharma Note 2.625%12/0 (Principal) | 1.4 | $50M | 17M | 3.04 | |
Deciphera Pharmaceuticals (DCPH) | 1.4 | $50M | 2.2M | 22.55 | |
Scholar Rock Hldg Corp (SRRK) | 1.3 | $46M | 2.9M | 15.86 | |
Krystal Biotech (KRYS) | 1.2 | $44M | 1.1M | 40.27 | |
Centene Corporation (CNC) | 1.0 | $36M | 691k | 52.44 | |
Gritstone Oncology Ord (GRTS) | 1.0 | $36M | 3.2M | 11.14 | |
UnitedHealth (UNH) | 1.0 | $35M | 142k | 244.01 | |
Anaptysbio Inc Common (ANAB) | 1.0 | $34M | 610k | 56.42 | |
Xeris Pharmaceuticals | 1.0 | $34M | 3.0M | 11.44 | |
Syros Pharmaceuticals | 0.9 | $34M | 3.6M | 9.26 | |
Axonics Modulation Technolog (AXNX) | 0.9 | $33M | 814k | 40.97 | |
Replimune Group (REPL) | 0.9 | $32M | 2.2M | 14.66 | |
Teladoc (TDOC) | 0.9 | $31M | 462k | 66.41 | |
Livanova SHS (LIVN) | 0.9 | $31M | 424k | 71.96 | |
ImmunoGen | 0.9 | $30M | 14M | 2.17 | |
Stoke Therapeutics (STOK) | 0.8 | $30M | 1.0M | 29.17 | |
Eidos Therapeutics | 0.8 | $27M | 878k | 31.08 | |
Odonate Therapeutics Ord | 0.8 | $27M | 741k | 36.69 | |
Dex (DXCM) | 0.7 | $26M | 172k | 149.84 | |
Tcr2 Therapeutics Inc cs | 0.7 | $26M | 1.8M | 14.31 | |
Oxford Immunotec Global Ord Shs | 0.7 | $25M | 1.8M | 13.76 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.7 | $24M | 168k | 142.56 | |
Glycomimetics (GLYC) | 0.7 | $24M | 2.0M | 11.92 | |
Alder Biopharmaceuticals Note 2.500% 2/0 (Principal) | 0.7 | $23M | 25M | 0.93 | |
Cymabay Therapeutics | 0.6 | $23M | 3.1M | 7.16 | |
Akero Therapeutics (AKRO) | 0.6 | $22M | 1.2M | 19.15 | |
Vapotherm | 0.6 | $22M | 960k | 23.00 | |
Atreca Cl A Com (BCEL) | 0.6 | $22M | 1.1M | 18.84 | |
Adaptive Biotechnologies Cor (ADPT) | 0.6 | $21M | 425k | 48.30 | |
Morphosys Sponsored Ads (MOR) | 0.5 | $18M | 734k | 24.14 | |
BioMarin Pharmaceutical (BMRN) | 0.5 | $17M | 197k | 85.65 | |
Chimerix (CMRX) | 0.4 | $15M | 3.6M | 4.32 | |
Hookipa Pharma Inc equity (HOOK) | 0.4 | $13M | 1.9M | 6.73 | |
Personalis Ord (PSNL) | 0.3 | $11M | 400k | 27.15 | |
Logicbio Therapeutics | 0.3 | $11M | 815k | 13.00 | |
Global Blood Therapeutics In | 0.3 | $9.9M | 188k | 52.60 | |
G1 Therapeutics (GTHX) | 0.3 | $9.0M | 293k | 30.66 | |
Invitae (NVTAQ) | 0.2 | $8.8M | 375k | 23.50 | |
Principia Biopharma | 0.2 | $8.1M | 244k | 33.19 | |
Gossamer Bio (GOSS) | 0.2 | $5.5M | 249k | 22.18 | |
Beigene Sponsored Adr (BGNE) | 0.1 | $4.9M | 40k | 123.96 | |
Avedro | 0.1 | $4.2M | 216k | 19.64 | |
Forty Seven | 0.1 | $2.5M | 234k | 10.60 | |
Ovid Therapeutics (OVID) | 0.0 | $1.4M | 738k | 1.85 | |
Jounce Therapeutics | 0.0 | $1.3M | 255k | 4.95 | |
Endologix Com New | 0.0 | $570k | 79k | 7.24 | |
Vericel (VCEL) | 0.0 | $316k | 17k | 18.90 | |
Myokardia | 0.0 | $313k | 6.3k | 50.06 | |
Amedisys (AMED) | 0.0 | $282k | 2.3k | 121.55 | |
Horizon Therapeutics Pub SHS | 0.0 | $274k | 11k | 24.04 | |
Flexion Therapeutics | 0.0 | $266k | 22k | 12.30 | |
Adverum Biotechnologies | 0.0 | $264k | 22k | 11.87 | |
LHC | 0.0 | $259k | 2.2k | 119.58 | |
Neurocrine Biosciences (NBIX) | 0.0 | $231k | 2.7k | 84.31 | |
Nevro (NVRO) | 0.0 | $220k | 3.4k | 64.71 | |
Establishment Labs Holdings Ord (ESTA) | 0.0 | $220k | 10k | 22.00 | |
Viking Therapeutics (VKTX) | 0.0 | $135k | 16k | 8.30 | |
Castlight Health CL B | 0.0 | $33k | 10k | 3.23 |